We came across a bullish thesis on Halozyme Therapeutics, Inc. on 24K Research’s Substack. In this article, we will summarize the bulls’ thesis on HALO. Halozyme Therapeutics, Inc.'s share was trading at $70.98 as of February 20th. HALO’s trailing and forward P/E were 16.41 and 8.19, respectively according to Yahoo Finance.
[caption id="attachment_399058" align="aligncenter" width="750"]Halozyme Therapeutics Inc (HALO), based in San Diego, California, is a pharmaceutical technology company that has built a high-margin, royalty-driven...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.